Fmoc-Val-Cit-PAB-OH
|
F404483-5g
|
≥97% |
159858-22-7 |
5g
|
¥ 820.9
|
期货,请咨询 |
阿拉丁 |
Fmoc-Val-Cit-PAB-OH
|
F404483-250mg
|
≥97% |
159858-22-7 |
250mg
|
¥ 92.9
|
现货 |
阿拉丁 |
Fmoc-Val-Cit-PAB-OH
|
F404483-1g
|
≥97% |
159858-22-7 |
1g
|
¥ 253.9
|
现货 |
阿拉丁 |
N-[6-(2,5-二氧代-2,5-二氢-1H-吡咯-1-基)己酰基]-L-缬氨酰-N5-(氨基甲酰基)-[4-(羟基甲基)苯基]-L-鸟氨酰胺
|
M404741-1g
|
≥97% |
159857-80-4 |
1g
|
¥ 1499.9
|
现货 |
阿拉丁 |
(E/Z)-BCI
|
Z412154-50mg
|
≥98% |
15982-84-0 |
50mg
|
¥ 10299.9
|
现货 |
阿拉丁 |
(E/Z)-BCI
|
Z412154-10mg
|
≥98% |
15982-84-0 |
10mg
|
¥ 3295.9
|
现货 |
阿拉丁 |
Ulipristal
|
U129252-50mg
|
≥98% |
159811-51-5 |
50mg
|
¥ 1992.9
|
现货 |
阿拉丁 |
Ulipristal
|
U129252-10mg
|
≥98% |
159811-51-5 |
10mg
|
¥ 854.9
|
现货 |
阿拉丁 |
1-叔丁氧羰基-4-亚甲基哌啶
|
T161652-25g
|
≥96%(GC) |
159635-49-1 |
25g
|
¥ 228.9
|
现货 |
阿拉丁 |
1-叔丁氧羰基-4-亚甲基哌啶
|
T161652-100g
|
≥96%(GC) |
159635-49-1 |
100g
|
¥ 784.9
|
现货 |
阿拉丁 |
ME-401
|
M414266-50mg
|
≥98% |
1595129-71-7 |
50mg
|
¥ 4819.9
|
现货 |
阿拉丁 |
ME-401
|
M414266-10mg
|
≥98% |
1595129-71-7 |
10mg
|
¥ 1409.9
|
现货 |
阿拉丁 |
ME-401
|
M414266-100mg
|
≥98% |
1595129-71-7 |
100mg
|
¥ 9887.9
|
现货 |
阿拉丁 |
CW069
|
C413741-50mg
|
≥99% |
1594094-64-0 |
50mg
|
¥ 3760.9
|
现货 |
阿拉丁 |
CW069
|
C413741-10mg
|
≥99% |
1594094-64-0 |
10mg
|
¥ 679.9
|
现货 |
阿拉丁 |
2,2-二甲基丙-1-胺盐酸盐
|
D191210-100g
|
≥95% |
15925-18-5 |
100g
|
¥ 3604.9
|
现货 |
阿拉丁 |
Dihydrocephalomannine
|
D350005-1mg
|
≥98% |
159001-25-9 |
1mg
|
¥ 598.9
|
现货 |
阿拉丁 |
孟鲁司特
|
M413330-5g
|
Moligand™, ≥99% |
158966-92-8 |
5g
|
¥ 5752.9
|
现货 |
阿拉丁 |
孟鲁司特
|
M413330-250mg
|
Moligand™, ≥99% |
158966-92-8 |
250mg
|
¥ 400.9
|
现货 |
阿拉丁 |
孟鲁司特
|
M413330-1g
|
Moligand™, ≥99% |
158966-92-8 |
1g
|
¥ 1507.9
|
现货 |
阿拉丁 |
孟鲁司特
|
M413330-100mg
|
Moligand™, ≥99% |
158966-92-8 |
100mg
|
¥ 195.9
|
现货 |
阿拉丁 |
KIRA6
|
K414099-50mg
|
≥98% |
1589527-65-0 |
50mg
|
¥ 3314.9
|
现货 |
阿拉丁 |
KIRA6
|
K414099-2mg
|
≥98% |
1589527-65-0 |
2mg
|
¥ 397.9
|
现货 |
阿拉丁 |
KIRA6
|
K414099-10mg
|
≥98% |
1589527-65-0 |
10mg
|
¥ 946.9
|
现货 |
阿拉丁 |